 |
市場調查報告書
商品編碼
1198808
白色生物技術市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)White Biotech Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
白色生物技術市場預計在預測期內（2022 年至 2027 年）的複合年增長率為 15.14%。
COVID-19 大流行在製藥行業的創新方面對白色生物技術市場產生了重大影響，證明了該類別的有利市場增長。 消費者對綠色化學品的需求不斷增長，主要在北美和歐洲等發達地區，願意為許多可再生產品支付更高的價格或綠色溢價，而製造商也願意為傳統產品支付 預計將鼓勵採用白色生物技術工藝代替化學製造。 包括汽車和消費品在內的各種消費行業正在增加實現可持續發展目標的需求，預計這將在預測期內推動對技術的需求。
工業生物技術或白色生物技術是控制污染、節約資源和降低成本的最有前途的方法之一。 這通常被稱為第三次生物技術浪潮。 使用白色生物技術可以減少50%的二氧化碳排放、20%的能源消耗和75%的水消耗。
白色生物技術市場趨勢
消費者對環保產品的需求增加
越來越多的消費者在做出購買決定時將環境考慮在內。 這種採購模式向零售商和製造商表明，質量和價格以外的因素也很重要，從而增加了對生物基和可持續產品的需求。 生物基產品具有保護有限化石資源、減少溫室氣體排放、提供高生物降解性和完全相容性的潛力。 消費者行為，尤其是在歐洲和美國，越來越受到綠色產品質量的影響，最近的研究表明，消費者願意為更具可持續性的產品支付溢價。 這樣，隨著環保意識的提高，預計對使用清潔和綠色製造工藝製造的產品（包括生物基產品）的需求將會增加。 杜邦綠色生活進行的研究。 調查發現，超過 63% 的消費者表示他們熟悉綠色產品，其中 85% 的消費者認為它們對環境有益。 這些消費者認為生物基成分不僅使產品更環保，而且性能更好，這對於長期採用很重要。
增長最快的白色生物技術市場是亞太地區
在過去十年中，中國的生物技術產業發展迅速，其核心是醫療技術和生物製劑。 隨著市場上的生物技術改性食品成分的增加，這種增長正在升級。 因此，玩家正在戰略性地投資本地公司。 例如，2021 年巴斯夫風險投資公司 (BVC) 將投資中國杭州的工業合成生物技術公司博塔生物科技有限公司 (Bota Bio)，以開發下一代生物技術平台來開發甜味劑，從而實現可持續且經濟的生產用於廣泛工業應用的高價值產品，例如維生素、個人護理或作物保護產品。 除了上述工業應用，由於消費者對營養食品和飲料的偏好日益增加，白色生物技術在日本的功能性食品和飲料領域具有巨大潛力。 因此，生物化學品和工業□為日本食品和飲料行業提供了巨大的機遇。
白色生物技術市場的競爭對手分析
白色生物技術市場競爭激烈，區域和全球參與者眾多。 很大一部分需求是由消費者對可持續性和高效生產力的意識驅動的。 因此，在市場上運營的參與者正在嘗試人口統計定位。 Corbion、ADM 和 DuPont 等幾家知名企業正通過瞄準市場的新配方和設計市場上各種未開發的微生物，專注於開發新的創新產品。
其他好處
- Excel 格式的市場預測 (ME) 表
- 三個月的分析師支持
內容
第一章介紹
- 研究假設和市場定義
- 調查範圍
第二章研究方法論
第 3 章執行摘要
第四章市場動態
- 市場驅動因素
- 市場製約因素
- 波特的五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第 5 章市場細分
- 按類型
- 生物燃料
- 生物材料
- 生物化學
- 工業□
- 通過使用
- 化學品
- 醫藥
- 食品和飲料行業
- 提要
- 其他用途
- 按地區
- 北美
- 美國
- 加拿大
- 墨西哥
- 其他北美地區
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 意大利
- 其他歐洲地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 其他亞太地區
- 南美洲
- 巴西
- 阿根廷
- 其他南美洲
- 中東
- 南非
- 沙特阿拉伯
- 其他中東地區
- 北美
第六章競爭格局
- 最活躍的公司
- 最常採用的策略
- 市場份額分析
- 公司簡介
- EUCODIS Bioscience GmbH
- DuPont
- Koninklijke DSM NV
- BASF SE
- Evonik Industries AG
- Lonza Group Ltd
- Laurus Labs
- Corbion NV
- Novozymes
- Archer Daniels Midland Company
第七章市場機會與未來趨勢
第 8 章 COVID-19 對市場的影響
The white biotech market is projected to register a CAGR of 15.14% during the forecast period (2022-2027).
The COVID-19 pandemic significantly impacted the white biotechnology market in terms of innovation in the pharmaceutical industry, which indicates a profitable market growth in the category. The rising consumer demand for green chemicals, majorly in developed regions like North America and Europe, is willing to pay a higher price or a green premium for numerous renewable products, which is expected to push manufacturers to employ white biotechnology processes instead of traditional chemical manufacturing. The rising need from various consumer industries, including automotive and consumer goods, to meet the sustainability targets is expected to fuel technology demand over the forecast period.
Industrial biotechnology or white biotechnology is one of the most promising approaches to pollution prevention, resource conservation, and cost reduction. It is often referred to as the third wave in biotechnology. The use of white biotechnology can reduce carbon dioxide emissions by as much as 50%, energy consumption by 20%, and water consumption by 75%.
White Biotech Market Trends
Increasing Consumer Demand for Products with Low Environmental Impacts
Consumers are increasingly making purchasing decisions based on environmental considerations. Such buying patterns also signal retailers and manufacturers that factors in addition to quality and price are important, hence boosting the demand for bio-based or sustainable products. Bio-based products have the potential to save on limited fossil resources, reduce greenhouse gas emissions, and offer high bio-degradability and full composability. Consumer behavior, especially in Europe and North America, is increasingly affected by green product qualities, and recent research shows consumers' willingness to pay a premium for more sustainable products. Thus, as environmental awareness grows, the demand for products from clean, green manufacturing processes, including bio-based products, is likely to grow. DuPont Green Living conducted a survey; in the survey, more than 63% of consumers are said to be familiar with green products, and of those, 85% have confidence that they are better for the environment. These consumers believe bio-based ingredients make not only a product green but also provide a better performance, which is critical to long-term adoption.
Asia-Pacific is the Fastest-growing Region in the White Biotech Market
China's biotech industry has grown rapidly over the past decade, and it is dominated by medical technologies and biologics. The growth is escalated by the biotechnologically altered food ingredients in the market. Thus, players are strategically investing in local companies. For instance, in 2021, BASF Venture Capital (BVC) invested in Bota Biosciences Ltd (Bota Bio), an industrial synthetic biotech company located in Hangzhou, China, which develops next-generation biotechnology platforms, enabling sustainable and economical production of high-value products for a broad array of industrial applications, like sweeteners, vitamins, personal care, or crop protection products. In addition to the above-mentioned industrial applications, white biotech has paved great opportunity in Japan's functional food and beverage segment due to the increased consumer inclinational toward food and beverage with high nutritional claims. Thus, biochemicals and industrial enzymes are paving great opportunities in the country's food and beverage domain.
White Biotech Market Competitor Analysis
The white biotech market is highly competitive, with a strong presence of regional and global players. The demand is mostly driven by consumer awareness of sustainability and efficient productivity. Thus, the players operating in the market are trying to position themselves according to the demographic group. Some prominent players, like Corbion, ADM, and DuPont, have been focusing on developing new and innovative products by targeting the new formulation for the market and engineering the various unexplored microorganisms in the market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Drivers
- 4.2 Market Restraints
- 4.3 Porter's Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Bargaining Power of Buyers/Consumers
- 4.3.3 Bargaining Power of Suppliers
- 4.3.4 Threat of Substitute Products
- 4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
- 5.1 By Type
- 5.1.1 Biofuels
- 5.1.2 Biomaterials
- 5.1.3 Biochemicals
- 5.1.4 Industrial Enzymes
- 5.2 By Application
- 5.2.1 Chemicals
- 5.2.2 Pharmaceuticals
- 5.2.3 Food and Beverages
- 5.2.4 Feed
- 5.2.5 Other Applications
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.1.4 Rest of North America
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Spain
- 5.3.2.5 Italy
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 Rest of Asia-Pacific
- 5.3.4 South America
- 5.3.4.1 Brazil
- 5.3.4.2 Argentina
- 5.3.4.3 Rest of South America
- 5.3.5 Middle-East
- 5.3.5.1 South Africa
- 5.3.5.2 Saudi Arabia
- 5.3.5.3 Rest of Middle-East
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Most Active Companies
- 6.2 Most Adopted Strategies
- 6.3 Market Share Analysis
- 6.4 Company Profiles
- 6.4.1 EUCODIS Bioscience GmbH
- 6.4.2 DuPont
- 6.4.3 Koninklijke DSM NV
- 6.4.4 BASF SE
- 6.4.5 Evonik Industries AG
- 6.4.6 Lonza Group Ltd
- 6.4.7 Laurus Labs
- 6.4.8 Corbion NV
- 6.4.9 Novozymes
- 6.4.10 Archer Daniels Midland Company
